Correlation Between Rimrock Gold and OncoVista Innovative

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rimrock Gold and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rimrock Gold and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rimrock Gold Corp and OncoVista Innovative Therapies, you can compare the effects of market volatilities on Rimrock Gold and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rimrock Gold with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rimrock Gold and OncoVista Innovative.

Diversification Opportunities for Rimrock Gold and OncoVista Innovative

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rimrock and OncoVista is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Rimrock Gold Corp and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and Rimrock Gold is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rimrock Gold Corp are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of Rimrock Gold i.e., Rimrock Gold and OncoVista Innovative go up and down completely randomly.

Pair Corralation between Rimrock Gold and OncoVista Innovative

Given the investment horizon of 90 days Rimrock Gold Corp is expected to generate 2.29 times more return on investment than OncoVista Innovative. However, Rimrock Gold is 2.29 times more volatile than OncoVista Innovative Therapies. It trades about 0.07 of its potential returns per unit of risk. OncoVista Innovative Therapies is currently generating about -0.12 per unit of risk. If you would invest  0.03  in Rimrock Gold Corp on December 22, 2024 and sell it today you would earn a total of  0.00  from holding Rimrock Gold Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy93.75%
ValuesDaily Returns

Rimrock Gold Corp  vs.  OncoVista Innovative Therapies

 Performance 
       Timeline  
Rimrock Gold Corp 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Rimrock Gold Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Rimrock Gold disclosed solid returns over the last few months and may actually be approaching a breakup point.
OncoVista Innovative 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days OncoVista Innovative Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Rimrock Gold and OncoVista Innovative Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rimrock Gold and OncoVista Innovative

The main advantage of trading using opposite Rimrock Gold and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rimrock Gold position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.
The idea behind Rimrock Gold Corp and OncoVista Innovative Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements